Article
Bioethical and clinical dilemmas of direct-to-consumer personal genomic testing: the problem of misattributed equivalence.
Science translational medicine - 3 Feb 2010
Eng Charis, Sharp Richard R
Abstract excerpt
A number of for-profit companies now provide personal genomic testing services to clients directly, without input from a physician or other health care provider, and the results of these tests include predictions about a broad spectrum of disease risks and traits. Validated clinical genetic testing and direct-to-consumer (DTC) genomic tests differ substantially in their reliability and usefulness, raising many...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
